Keros Therapeutics, Inc. (KROS) quarterly cash flow statement — complete operating, investing & financing history
Keros Therapeutics, Inc. (KROS) cash flow statement — 8-year operating, investing & financing cash flows
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 |
|---|
| Cash from Operations | 3.39M | -20.42M | -3.53M | -27.29M | 3.25M | -29.62M | 161.17M | -46.01M | -30.5M | -39.8M | -44.56M | -25.46M | -33.98M | -30.83M | -34.23M | -21.44M | -24.6M | -22.59M | -1.43M | -19.57M |
| Operating CF Margin % | 8.47% | - | -961.58% | -7088.83% | 22.78% | -163.05% | 76.3% | -1512.43% | -7860.82% | -107570.27% | -53686.75% | -17803.5% | -424775% | - | - | - | - | - | - | -97.82% |
| Operating CF Growth % | 4.34% | 31.06% | -102.19% | 40.68% | 110.65% | 25.57% | 461.69% | -80.71% | 10.25% | -29.09% | -30.16% | -18.73% | -38.13% | -36.49% | -2299.09% | -9.6% | -70.36% | -28.08% | 86.42% | -144.84% |
| Net Income | 14.15M | -28.71M | -23.71M | -23.46M | -7.28M | -30.7M | 148.45M | -46.03M | -52.96M | -45.26M | -43.11M | -40.24M | -39.44M | -37.51M | -35.8M | -29.72M | -23.51M | -27.27M | -24.19M | -6.94M |
| Depreciation & Amortization | 384K | 402K | 403K | 400K | 395K | 370K | 344K | 332K | 314K | 306K | 277K | 247K | 551K | 545K | 167K | 127K | 126K | 308K | 316K | 104K |
| Stock-Based Compensation | 4.2M | 5.38M | 6.2M | 7.3M | 3.99M | 8.54M | 8.86M | 9.2M | 8.82M | 8.79M | 8.07M | 7.32M | 0 | 0 | 5.69M | 4.75M | 4.75M | 4.79M | 0 | 3.29M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 26K |
| Other Non-Cash Items | -551K | 652K | 636K | 623K | 609K | 581K | 584K | 572K | 563K | 346K | 339K | 335K | 8.71M | 7.04M | 526K | 322K | 222K | 206K | 4.39M | 907K |
| Working Capital Changes | -14.8M | 1.86M | 12.94M | -12.16M | 5.54M | -8.42M | 2.93M | -10.09M | 12.76M | -3.98M | -10.13M | 6.88M | -3.8M | -913K | -4.81M | 3.08M | -6.2M | -632K | 18.05M | -16.96M |
| Change in Receivables | -20M | 400K | 3.17M | -2.33M | 12.32M | 1.48M | -14.55M | -2.35M | -384K | 222K | -83K | -143K | 0 | 0 | 0 | 0 | 0 | 0 | 18M | -18M |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.85M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 18M |
| Change in Payables | 1.97M | 323K | -108K | -697K | -2.96M | -1.37M | 2.02M | -293K | -1.59M | 1.61M | 23K | 1.04M | -182K | -570K | 1.32M | 595K | -4.99M | 4.66M | -668K | 823K |
| Cash from Investing | -59K | -155K | -73K | -134K | -132K | -720K | -565K | -289K | -386K | -310K | -946K | -541K | -550K | -311K | -1.06M | -351K | -176K | -567K | -147K | -159K |
| Capital Expenditures | -59K | -155K | -73K | -134K | -132K | -720K | -565K | -289K | -386K | -310K | -946K | -541K | -550K | -311K | -1.06M | -351K | -176K | -567K | -147K | -159K |
| CapEx % of Revenue | 0.15% | - | 19.89% | 34.81% | 0.93% | 3.96% | 0.27% | 9.5% | 99.48% | 837.84% | 1139.76% | 378.32% | 6875% | - | - | - | - | - | - | 0.8% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | -1.47M | -3.31M | -2.32M | -378.63M | 140K | 17K | 4K | 75.54M | 155.94M | 3.53M | 156.8M | 69.25M | 284K | 1.74M | 107.68M | 61.42M | 48.58M | 10.19M | 118K | 28.42M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 0 | 23K | 7K | 127K | 138K | 17K | 4K | 73.1M | 155.07M | 629K | 151.34M | 68.52M | 284K | 1.74M | 107.31M | 61.4M | 48.49M | 9.69M | 118K | 28.17M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 178K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -1.47M | -3.34M | -2.32M | -378.76M | 2K | 0 | 0 | 2.44M | 878K | 2.9M | 5.46M | 737K | 0 | 0 | 370K | 15K | 96K | 502K | 0 | 245K |
| Net Change in Cash | 3.31M | -23.89M | -5.92M | -406.06M | 3.26M | -30.33M | 160.61M | 29.25M | 125.06M | -36.58M | 111.3M | 43.25M | -34.13M | -29.4M | 72.38M | 39.62M | 23.8M | -12.96M | -1.46M | 8.69M |
| Free Cash Flow | 3.33M | -20.58M | -3.6M | -27.43M | 3.12M | -30.34M | 160.61M | -46.3M | -30.89M | -40.11M | -45.51M | -26M | -34.53M | -31.14M | -35.3M | -21.79M | -24.78M | -23.16M | -1.57M | -19.72M |
| FCF Margin % | 8.33% | - | -981.47% | -7123.64% | 21.86% | -167.01% | 76.03% | -1521.93% | -7960.31% | -108408.11% | -54826.51% | -18181.82% | -431650% | - | - | - | - | - | - | -98.62% |
| FCF Growth % | 6.87% | 32.19% | -102.24% | 40.76% | 110.09% | 24.35% | 452.93% | -78.07% | 10.56% | -28.8% | -28.92% | -19.3% | -39.37% | -34.49% | -2142.5% | -10.49% | -69.88% | -27.61% | 85.31% | -144.99% |
| FCF per Share | - | -1.04 | -0.18 | -1.01 | 0.08 | -0.75 | 3.92 | -1.15 | -0.86 | -1.11 | -1.55 | -0.86 | -1.16 | -1.05 | -1.24 | -0.80 | -0.97 | -0.96 | -0.07 | -0.84 |
| FCF Conversion (FCF/Net Income) | 0.24x | 0.71x | 0.15x | 1.16x | -0.45x | 0.97x | 1.09x | 1.00x | 0.58x | 0.88x | 1.03x | 0.63x | 0.86x | 0.82x | 0.96x | 0.72x | 1.05x | 0.83x | 0.06x | 2.82x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 4.89M | 750K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |